--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "ICU Trials by ClinCalc" developer_entity: "ClinCalc LLC" bundle_id: "clincalc.icutrials" app_store_id: "534227095" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2023-10-01" report_date: "2026-04-01" report_version: "2023.2" total_reviews: 66 overall_rating: 4.79 sentiment: "Thrilled" sentiment_score: 88 confidence: "medium" confidence_score: 0.6 data_age_days: 74 intelligence_version: 2 nemesis: "Critical Care Medicine" competitor_count: 11 tags: ["medical", "paid", "thrilled sentiment", "mobile app", "app review", "app analysis", "critical", "clinicians,", "including"] canonical_url: "https://marlvel.ai/intel-report/medical/clincalc-icutrials" license: "CC-BY-NC 4.0" last_verified: "2026-04-18T18:42:39.979Z" --- # ICU Trials by ClinCalc App Audit > **TL;DR:** ICU Trials by ClinCalc is a medical app by ClinCalc LLC, rated 4.79/5 by 66 users, with Thrilled user sentiment (88/100), available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** ICU Trials by ClinCalc maintains Thrilled user sentiment (4.79/5 from 66 reviews), with users consistently praising content quality and utility. ## Metadata & Market Performance - **Publisher:** ClinCalc LLC - **Category:** Medical - **Target Audience:** Critical care clinicians, including intensivists, residents, students, and pharmacists. - **Platforms:** iOS - **Version Audited:** 2023.2 - **Audit Date:** 2026-04-01 - **Signal Count:** 18 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 534227095 - **Bundle ID:** clincalc.icutrials - **Data Window:** Analysis based on signals collected up to 2026-04-01 ## Executive Snapshot ICU Trials by ClinCalc is a specialized, high-utility medical reference tool designed for critical care clinicians. It provides a curated library of over 150 landmark clinical trials, offering concise summaries and expert commentary for bedside decision-making. Positioned as a premium, ad-free professional resource, the app maintains a strong market presence in the Medical category, currently holding the #39 Paid rank. Its primary differentiator is the combination of expert-curated clinical context and a streamlined, high-yield interface that respects the time-constrained environment of the ICU. ## App DNA (Features & Intent) - **[Standard] Landmark Trial Summaries:** Concise, high-yield summaries of 150+ critical care trials including inclusion/exclusion criteria, protocols, and findings. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Expert Commentary:** Professional insights regarding subgroup analyses, methodologic limitations, and historical clinical context for each trial. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] PubMed Integration:** Direct links to original manuscripts and a 'Share Trial' feature to email citations and summaries to colleagues. * *User Intent:* Users seek social connection and competitive engagement with peers. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase of $4.99 - **Price:** iOS: $4.99 - **Analysis:** A straightforward, low-barrier paid model that appeals to medical professionals seeking a high-quality, ad-free, and reliable reference tool without recurring subscription costs. ## 🟢 User Sentiment (Medium Confidence: 66 reviews) {#user-sentiment} - **Overall Rating:** 4.79/5 - **Platform Split:** iOS 4.8/5 (66 ratings) - **Overall Sentiment:** Thrilled ### Top Praises - **Content Quality and Utility** | *Evidence:* "Offers concise summaries of over 100 landmark clinical trials" ### Top Complaints (Impact Areas) - **Lack of Feature Updates** | *Evidence:* "Wish it was updated more often" ## SWOT Analysis **Core Strengths:** - Expert-curated content - Ad-free professional UX - High user trust **Critical Frictions:** - Missing sync/notes features - Perceived slow update frequency - No social engagement **Growth Levers:** - Add user-defined notes/favorites - Implement content update roadmap - Expand specialty coverage **Market Threats:** - Large platforms adding similar features - AI-driven literature tools - Market saturation ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### ICU Trials by ClinCalc vs Critical Care Medicine — Head to Head - **Critical Care Medicine** by MedApps: Provides a direct, evidence-based reference library for ICU clinicians that mirrors the trial-summary format. - **Evidence-Based Medicine (EBM) Guidelines** by EBM Guidelines: Offers concise summaries of clinical trials and guidelines specifically tailored for bedside decision-making. ### Contenders (Strong Challengers) - **MDCalc Medical Calculator** by MedPrep: While calculator-focused, it provides extensive clinical trial references and evidence-based scoring systems for ICU settings. - **UpToDate** by Wolters Kluwer Health: The industry standard for clinical decision support, offering deeper, though less portable, trial summaries than ICU Trials. - **Medscape** by WebMD: Provides broad clinical reference material and news on landmark trials, acting as a generalist alternative to the niche ICU focus. ### Peers (What They Do Better) - **QxMD Calculate** by QxMD Software: A widely used clinical decision support tool that integrates trial-based evidence into bedside calculations. - **DynaMed** by EBSCO Industries: Provides evidence-based clinical summaries that compete for the clinician's time at the point of care. - **Epocrates** by athenahealth: Focuses on drug information and clinical references, serving as a primary utility app for the same target audience. - **Journal Club: Medicine** by Journal Club: Focuses specifically on summarizing landmark medical literature, though it covers a broader range of specialties than just ICU. ### New Kids on the Block (What's Innovative) - **Read by QxMD** by QxMD Software: Aggregates new landmark trials in real-time, offering a more dynamic, feed-based approach to staying current. - **Figure 1** by Figure 1 Inc.: Uses a social, case-based learning model that is increasingly capturing the attention of residents and specialists. ## The "So What?" (Strategic Takeaway) {#so-what} ICU Trials by ClinCalc is a market-leading medical app that is a paid app. With a 4.79/5 rating from 66 reviews, it delivers strong user satisfaction. **Strategic Opportunity:** While ICU Trials by ClinCalc benefits from expert-curated content, its vulnerability lies in missing sync/notes features. A challenger could exploit this by focusing on add user-defined notes/favorites. **Best for:** Critical care clinicians, including intensivists, residents, students, and pharmacists. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.79/5 | | Total Reviews | 66 | | Sentiment | Thrilled (88/100) | | Confidence | Medium | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **ICU Trials by ClinCalc** (this app) | 4.79/5 | Thrilled | ClinCalc LLC | | [Vulvar Pain Algorithm](https://marlvel.ai/intel-report/medical/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff | | [Total Reflexology-3D](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | | [CardioGenetics](https://marlvel.ai/intel-report/medical/com-scd-risk-calculator) | N/A/5 | N/A | MARK EMILE PEPIN | | [ECGsource](https://marlvel.ai/intel-report/medical/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC | | [My F1rst Steps](https://marlvel.ai/intel-report/medical/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC | ## Company Profile - **Developer:** ClinCalc LLC - **Website:** [https://clincalc.com/mobile/IcuTrials.aspx](https://clincalc.com/mobile/IcuTrials.aspx) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/icu-trials-by-clincalc/id534227095?uo=2) - **Dev Site:** [Official Website](https://clincalc.com/mobile/IcuTrials.aspx) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Vulvar Pain Algorithm*](https://marlvel.ai/intel-report/medical/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment - [*CardioGenetics*](https://marlvel.ai/intel-report/medical/com-scd-risk-calculator) (MARK EMILE PEPIN) — N/A Rating | N/A Sentiment - [*ECGsource*](https://marlvel.ai/intel-report/medical/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/intel-report/medical/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/intel-report/medical/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment - [*Pelvic Pain Pentad*](https://marlvel.ai/intel-report/medical/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/intel-report/medical/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment - [*Drug Facts by PillSync.com*](https://marlvel.ai/intel-report/medical/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment - [*Beat Social Phobia with AJ*](https://marlvel.ai/intel-report/medical/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 18 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 6 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/clincalc-icutrials) Data licensed for AI Agent attribution under CC-BY-NC 4.0.